Clermont Partners Announces Appointment of Annie Cheng as Managing Director in the Healthcare and Life Sciences Practice
April 21, 2015 – Clermont Partners, a boutique strategic communications firm with offices in New York and Chicago, is pleased to announce the appointment of Annie Cheng as Managing Director in the Healthcare and Life Sciences practice.
“Clermont provides its clients with experienced strategic counsel, and access to the capital markets through a combination of deep industry knowledge and high quality, long-tenured relationships required to engage with key stakeholders including investors, bankers, VCs and corporates,” said Barbara Ryan, Partner and Head of Healthcare and Life Sciences at Clermont Partners. “I am thrilled to have someone with Annie’s extensive capital markets experience as both a former sell-side research analyst and COO of an emerging public biotech company join our team.”
Ms. Cheng, who recently returned to New York from London, has over 15 years of experience in the healthcare sector. As a sell-side equity analyst, Annie covered emerging biotechnology and medical device companies at global investment banks and European boutiques, including Deutsche Bank in New York, JP Morgan in London, and French investment bank, Bryan, Garnier and Co. Subsequently, Annie advised a number of emerging biotech companies before joining Silence Therapeutics, where, as COO and member of their Board of Directors, she was responsible for fundraising, strategy, business development and communications.
For further information:
+1 (312) 690-6004
International and Media Inquiries:
+1 (917) 826-0344
About Clermont Partners
Clermont Partners offers a wide range of stakeholder relations counsel that addresses the nexus between financial communications and issues management. Its fundamental premise is a commitment to provide and execute sophisticated communications strategies which enable clients to realize their valuation and reputation objectives. Clermont Partners’ core capabilities are rooted in capital markets communications extending to global investor relations programs, mergers and acquisitions, IPOs and capital raisings, shareholder activism, complex corporate events, corporate and executive media programs, restructurings and the management of reputational and industry issues.
The team has more than 75 years of combined experience and broad sector knowledge, expertise and global relationships with institutional investors, analysts, investment bankers, venture capital and private equity firms, financial as well as trade media and other influencers across the Industrials, Healthcare and Life Sciences, Energy, Telecommunications, Media & Technology and Consumer industries. They have architected financial and corporate relations programs for companies undertaking major acquisitions or corporate transformations, executing award-winning investor relations programs or managing reputational issues and crises.